Therefore, to determine the impact of inhibition of IKK/NF-κB signaling on cell proliferation and survival, we treated HNSCC cells with the IKKβ inhibitor, CmpdA. The gene discussed is IKBKB; the disease is head and neck squamous cell carcinoma.